Lei, J., Dai, H., Zhang, Y., Ou, G., Liang, Z. P., Lu, Y., & Li, H. Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC. SAGE Publishing.
Chicago Style (17th ed.) CitationLei, Jin, Hongyuan Dai, Ya Zhang, Guangling Ou, Zhi Peng Liang, Yinying Lu, and Haiyang Li. Prognostic Impact of Primary Versus Secondary Resistance to Sorafenib in Patients with HCC. SAGE Publishing.
MLA (9th ed.) CitationLei, Jin, et al. Prognostic Impact of Primary Versus Secondary Resistance to Sorafenib in Patients with HCC. SAGE Publishing.
Warning: These citations may not always be 100% accurate.